1. Home
  2. VRNA vs LSCC Comparison

VRNA vs LSCC Comparison

Compare VRNA & LSCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • LSCC
  • Stock Information
  • Founded
  • VRNA 2005
  • LSCC 1983
  • Country
  • VRNA United Kingdom
  • LSCC United States
  • Employees
  • VRNA N/A
  • LSCC N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • LSCC Semiconductors
  • Sector
  • VRNA Health Care
  • LSCC Technology
  • Exchange
  • VRNA Nasdaq
  • LSCC Nasdaq
  • Market Cap
  • VRNA 8.3B
  • LSCC 9.8B
  • IPO Year
  • VRNA 2017
  • LSCC 1989
  • Fundamental
  • Price
  • VRNA $106.91
  • LSCC $71.36
  • Analyst Decision
  • VRNA Buy
  • LSCC Strong Buy
  • Analyst Count
  • VRNA 11
  • LSCC 11
  • Target Price
  • VRNA $114.10
  • LSCC $68.73
  • AVG Volume (30 Days)
  • VRNA 1.5M
  • LSCC 2.6M
  • Earning Date
  • VRNA 11-03-2025
  • LSCC 11-03-2025
  • Dividend Yield
  • VRNA N/A
  • LSCC N/A
  • EPS Growth
  • VRNA N/A
  • LSCC N/A
  • EPS
  • VRNA N/A
  • LSCC 0.23
  • Revenue
  • VRNA $221,673,000.00
  • LSCC $488,631,000.00
  • Revenue This Year
  • VRNA $909.96
  • LSCC $3.96
  • Revenue Next Year
  • VRNA $76.47
  • LSCC $19.53
  • P/E Ratio
  • VRNA N/A
  • LSCC $311.70
  • Revenue Growth
  • VRNA N/A
  • LSCC N/A
  • 52 Week Low
  • VRNA $31.09
  • LSCC $34.69
  • 52 Week High
  • VRNA $106.94
  • LSCC $76.62
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 72.60
  • LSCC 55.79
  • Support Level
  • VRNA $105.78
  • LSCC $71.89
  • Resistance Level
  • VRNA $106.86
  • LSCC $75.22
  • Average True Range (ATR)
  • VRNA 0.16
  • LSCC 2.54
  • MACD
  • VRNA -0.04
  • LSCC -0.37
  • Stochastic Oscillator
  • VRNA 98.26
  • LSCC 38.36

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

Share on Social Networks: